Long-Term Safety and Efficacy of HB0034 in Subjects With Generalized Pustular Psoriasis
Clinical trial NCT06477536 · RECRUITING
Trial details
- NCT number
- NCT06477536
- Sponsor
- Shanghai Huaota Biopharmaceutical Co., Ltd.
- Status
- RECRUITING
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2024-09-02
- Primary completion
- 2025-12-30
- Enrollment
- 33
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.